Not yet recruiting
Effect of Albumin Therapy in Mechanically Ventilated Patients With Sepsis-Associated ARDS
NCT07857928· The Second Affiliated Hospital of Hainan Medical University· Source
Contact: Fengyun Wang, MD/PhD
Recruiting
A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07795346· Phase 3· Antengene Biologics Limited· Source
Contact: Erxia He
Not yet recruiting
Effects of a Perma-h Model Mobile-based Rehabilitation Support Program on Hope, Self-efficacy, Perceived Social Support and Rehabilitation Outcomes in Post- Tracheostomy Oral Cancer Patients
NCT07714967· Hainan Medical College· Source
Contact: Mingxiang Li, Master
Not yet recruiting
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
NCT07242599· Phase 3· Beijing Tiantan Hospital· Source
Contact: Bin Chen
Recruiting
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.
NCT07385703· Phase 3· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Source
Contact: Erxia He, Master
Not yet recruiting
Comparison of the Therapeutic Effects of Methylprednisolone and Dexamethasone on Peritumoral Edema During Radiotherapy for Brain Metastases:
NCT07542288· Phase 2/3· The Second Affiliated Hospital of Hainan Medical University· Source
Contact: yuecan zeng
Recruiting
A Study Investigating the Efficacy and Safety of the Combination of Iparomlimab and Tuvonralimab With or Without Chemotherapy in Second-line and Subsequent Treatments for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT07546383· The Second Affiliated Hospital of Hainan Medical University· Source
Contact: yuecan zeng, doctor
Not yet recruiting
Butylphthalide for Brain Edema After Endovascular Treatment
NCT07528456· Phase 4· Nanfang Hospital, Southern Medical University· Source
Contact: Kaibin Huang, PhD
Not yet recruiting
A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs
NCT07483684· Phase 3· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Source
Contact: Erxia He, Master
Not yet recruiting
PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy
NCT07174375· Phase 2/3· Nanfang Hospital, Southern Medical University· Source
Contact: Pengxiang Li, M.D.
Recruiting
Topical Diclofenac for Prevention of Radiation-induced Dermatitis
NCT06905561· The Second Affiliated Hospital of Hainan Medical University· Source
Contact: yuecan zeng, doctor
Recruiting
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
NCT06548971· Phase 3· Capital Medical University· Source
Contact: Bin Liu
Recruiting
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy(RECAST-MT)
NCT06559241· Phase 3· Capital Medical University· Source
Contact: Bin Chen
Active, not recruiting
Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
NCT06360458· Phase 3· Wan-Jin Chen· Source
Active, not recruiting
A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer
NCT06984588· Phase 2/3· TJ Biopharma Co., Ltd.· Source
Recruiting
A Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
NCT06049290· Phase 1/2· Nanjing Leads Biolabs Co.,Ltd· Source
Contact: DongTao Meng
Recruiting
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
NCT05862337· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source
Contact: Haifeng Lin, Bachelor
Active, not recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
NCT05253651· Phase 3· Seagen, a wholly owned subsidiary of Pfizer· Source
Recruiting
A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
NCT05851014· Phase 3· Genor Biopharma Co., Ltd.· Source
Contact: Chaoying Wang, Bachelor
Not yet recruiting
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
NCT04995159· Lepu Medical Technology (Beijing) Co., Ltd.· Source
Contact: Yuewu Chen